Tashee Health Ltd - Period Ending 2023-02-28

Tashee Health Ltd - Period Ending 2023-02-28


Tashee Health Ltd 10033007 false 2022-03-01 2023-02-28 2023-02-28 The principal activity of the company is that of a research nature into health products. Digita Accounts Production Advanced 6.30.9574.0 true 10033007 2022-03-01 2023-02-28 10033007 2023-02-28 10033007 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 10033007 bus:Micro-entities 2022-03-01 2023-02-28 10033007 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 10033007 bus:FullAccounts 2022-03-01 2023-02-28 10033007 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 10033007 bus:RegisteredOffice 2022-03-01 2023-02-28 10033007 bus:Director2 2022-03-01 2023-02-28 10033007 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 10033007 countries:EnglandWales 2022-03-01 2023-02-28 10033007 2021-03-01 2022-02-28 10033007 2022-02-28 10033007 core:CurrentFinancialInstruments core:WithinOneYear 2022-02-28 iso4217:GBP xbrli:pure

Registration number: 10033007

Prepared for the registrar

Tashee Health Ltd

Unaudited Financial Statements

for the Year Ended 28 February 2023

 

Tashee Health Ltd

(Registration number: 10033007)
Balance Sheet as at 28 February 2023

2023
£

2022
£

Fixed assets

3,640

4,066

Current assets

3,710

2,657

Creditors: Amounts falling due within one year

(360,950)

(291,369)

Net current liabilities

(357,240)

(288,712)

Total assets less current liabilities

(353,600)

(284,646)

Accruals and deferred income

(1,625)

(1,500)

 

(355,225)

(286,146)

Capital and reserves

(355,225)

(286,146)

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

2023
 No.

2022
 No.

Average number of employees

3

5

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the financial year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the Board on 28 November 2023 and signed on its behalf by:
 

.........................................
S Shukla
Director